Age, Biography and Wiki
Bill Anderson (businessman) was born on 23 August, 1966 in Ohio, Texas, U.S., is an American business executive (born 1966). Discover Bill Anderson (businessman)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 57 years old?
| Popular As |
N/A |
| Occupation |
Business executive Chemical engineer |
| Age |
57 years old |
| Zodiac Sign |
Leo |
| Born |
23 August, 1966 |
| Birthday |
23 August |
| Birthplace |
Ohio, Texas, U.S. |
| Nationality |
|
We recommend you to check the complete list of Famous People born on 23 August.
He is a member of famous Business Executive with the age 57 years old group.
Bill Anderson (businessman) Height, Weight & Measurements
At 57 years old, Bill Anderson (businessman) height not available right now. We will update Bill Anderson (businessman)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
3 |
Bill Anderson (businessman) Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Bill Anderson (businessman) worth at the age of 57 years old? Bill Anderson (businessman)’s income source is mostly from being a successful Business Executive. He is from . We have estimated Bill Anderson (businessman)'s net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Business Executive |
Bill Anderson (businessman) Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023.
Anderson was born on August 23, 1966, in Ohio, Texas.
He holds a bachelor's degree in chemical engineering from the University of Texas at Austin and a master's degree in management and chemical engineering from the Massachusetts Institute of Technology (MIT).
Anderson is married and has three children.
Anderson started his career in 1989 as a process engineer for research and development at Ethyl Corporation in the Netherlands and Belgium.
From 1995 to 1997, he worked as a marketing manager for Raychem.
From 1997 to 2006, Anderson worked at Biogen in multiple countries, including, Ireland, the U.S., and the U.K., holding positions such as vice president and general manager of the neurology business at Biogen.
In 2006, Anderson joined Genentech, where he eventually became the senior vice president of the immunology, ophthalmology and bio-oncology divisions.
In 2013, Anderson moved to Switzerland to be head of global product strategy and chief marketing officer of the pharmaceuticals division at the Roche Holding AG.
In July 2016, Anderson returned to the U.S. to lead North American Operations at Roche's subsidiary, Genentech.
Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.
From 2017 to 2018, he was the CEO of Genentech.
While at Genentech, he developed its immunology and ophthalmology divisions, managed the sales of Rituxan, Raptiva, and Xolair, and directed Roche's late-stage portfolio committee for nearly four years, where he was responsible for determining late-stage clinical trial advancements.
From 2019 to 2022, Anderson was CEO of Roche's pharmaceuticals division.
During Anderson's tenure at Roche, he facilitated the company's transition from a focus on oncology.
He headed the development and launch of new drugs to compensate for the decrease in revenues from oncology drugs whose patents had expired.
On June 1, 2023, Anderson assumed the role of CEO of Bayer AG, succeeding Werner Baumann.
The selection process had begun in mid-2022 and by April 2023, he became a member of the Board of Management of Bayer AG.
He is the second foreigner to lead Bayer after Marijn Dekkers, and like Dekkers, he is the second CEO in Bayer's history to be hired from outside the company.
